2International Union of Pure and Applied Chemistry,International Federation of Clinical Chemistry(2000).Properties and units in the clinical laboratory sciences:Part X.Properties and units in general clinical chemistry[J].Pure Appl Chem,2000,72(4):747-972.
3Wu AHB.A selected history and future of immunoassay development and applications in clinical chemistry[J].Clin Chim Acta,2006,369(2):119-124.
4Iervasi A,Zucchelli GC,Turchi S,et al.Analytical and clinical performance of an automated chemiluminescent immunoassay for direct renin measurement:comparison with PRA and aldosterone assays[J].Immunoanalyse & Biologie Spccialisee,2005,20(4):257-262.
5Zhang YX,Zhang ZJ,Yang F.A sensitive immunoassay for determination of hepatitis B surface antigen and antibody in human serum using capillary electrophoresis with chemiluminescence detection[J].J Chromatog B,2007,857(1):100-107.
5NCCLS. Method comparison and bias estimation using patient samples;NCCLS document EP9-A2[S]. Wayne, PA: NCCLS, 2002.
6National Committee for Clinical Laboratory Standards. Method comparison and bias estimation using patient samples[S]. Approved Guideline, 2nd ed, EP9-A2, 2002.
7Kohen F., Pazzagli M., Kim J B., Lindner H R, Boguslaski R C. An assay procedure for plasma progesterone based on antibodyenhanced chemiluminescence. FEBS Letter., 1979, 104:201-205
8Pazzagli M. , Bolelli G F. , Messeri G. Homogeneous luminescent immunoassay for progesterone study of the antibody-enhanced chemiluminescence. Serono Symp Publ Raven Press, 1982, 191 -200 through CA97: 4984w
9Kim J B., Kohen F. , Lindner H R. Collins W P. Measurement of plasma progesteroney a solid-phase chemiluminescence immunoassay method. Serono Symp PUBL Raven Presbs, 1982, 201 -206through CA97: 33498z
10Kiohen F. , Kim J B., Lindner H R. Collins W R. Development of solid-phase chemiluminescence immunoassay for plasma progesterone. Steriods, 1981,38:73-88
6Nevalainen D,Berte L,Kraft C,et al.Evaluating laboratory perform ance on quality indicators with the six sigma scale[J].Arch Pathol Lab Med,2000,124(4):516-519.
7Ricós C,García-Lario JV,Alvares V,et al.Biological variation database,and quality specifications for imprecision,bias and total error (desirable and minimum):the 2010 update[J/OL].[2011-09-14].http://www.westgard.com/biodatabase-2010-update.htm.
10Hamilton TE. Thyrotropin Levels in a population with no clinical, autoantibody, or ultrasonographic evidence of thy- roid disease:Implications for the diagnosis of subclinical hypothyroidism [J]. J Clin Endoerinol Metab,2008,93 (4) : 1224-1230.
